References |
1 |
Levocarnitine and muscle metabolism in patients with end-stage renal disease J Ren Nutr. 1998 Jul;8(3):118-21. doi: 10.1016/s1051-2276(98)90001-2.
|
2 |
DrugBank(Pharmacology-Metabolism)Levocarnitine
|
3 |
DrugBank(Pharmacology-Metabolism)Adenosine
|
4 |
Purine signaling pathway dysfunction in autism spectrum disorders: Evidence from multiple omics data. Front Mol Neurosci. 2023 Feb 3;16:1089871. doi: 10.3389/fnmol.2023.1089871.
|
5 |
Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist. J Clin Pharmacol. 2015 Sep;55(9):1004-11.
|
6 |
Condition-dependent adenosine monophosphate decomposition pathways in striated adductor muscle from Japanese scallop (Patinopecten yessoensis) J Food Sci. 2020 May;85(5):1462-1469. doi: 10.1111/1750-3841.15142.
|